The health-related quality of life and cost implications of falls in elderly women

Original Article

Abstract

Summary

Fractures and falls are serious cause of morbidity and cost to society. Our results suggest that the main burden to morbidity, measured as impact on health-related quality of life, is due to fear of falling rather than falls or their sequelae, such as fractures.

Introduction

Fractures and falls are serious cause of morbidity and cost to society. We investigated the impact on health-related quality of life (HRQoL) associated with falls, fractures and fear of falling and falls and fractures cost.

Methods

Three datasets providing longitudinal data on fear of falling, HRQoL and a common set of baseline risk factors for fracture (smoking status, weight and age) were analysed. Multilevel random effects models were used to estimate the long-term impact on HRQoL associated with falls, fractures and fear of falling. Healthcare resource use primary data were collected to estimate falls and fractures cost.

Results

Older, low weight and smoking women reported lower HRQoL. The impact on HRQoL of a fracture was at least twice as large as that associated with falls. The largest negative effect on HRQoL was associated with self-reported fear of falling. The cost of falls was £1088. Similarly, the cost of falls leading to a fracture was £15,133, £2,753, £1,863, £1,331 and £3,498 for hip, wrist, arm, vertebral and other fractures, respectively.

Discussion

The main burden to morbidity is due to fear of falling. Interventions aimed at reducing fear of falling may produce larger gains in HRQoL.

Keywords

EQ-5D Falls Fear of falling Multilevel modelling Quality of life 

References

  1. 1.
    Fraser WD (2004) The burden of osteoporosis and the case for disease management. Disease Management and Health Outcomes 12:409–418CrossRefGoogle Scholar
  2. 2.
    UK Department of Health (2001) National service framework for older people. Department of Health, LondonGoogle Scholar
  3. 3.
    Torgerson DJ Iglesias CP Reid DM (2001) The economics of fracture prevention. In Barlow DH, Francis RM, Miles A (eds) The effective management of osteoporosis. Aesculapius Medical, London, pp 111–121Google Scholar
  4. 4.
    OECD—Organisation for Economic Co-operation and Development (2007) Purchasing power parities (PPP). http://www.oecd.org/std/ppp
  5. 5.
    Daly E, Vessey MP, Barlow D, Gray A, McPherson K, Roche M (1996) Hormone replacement therapy in a risk-benefit perspective. Maturitas 23:247–259PubMedCrossRefGoogle Scholar
  6. 6.
    Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M (1993) Measuring the impact of menopausal symptoms on quality of life. Br Med J 307:836–840CrossRefGoogle Scholar
  7. 7.
    Coyle D, Cranney A, Lee KM, Welch V, Tugwell P (2001) Cost effectiveness of nasal calcitonin in postmenopausal women: use of cochrane collaboration methods for meta-analysis within economic evaluation. PharmacoEconomics 19:565–575PubMedCrossRefGoogle Scholar
  8. 8.
    Lawrence TM, White CT, Wenn R, Moran CG (2005) The current hospital costs of treating hip fractures. J Care Injured 36:88–91Google Scholar
  9. 9.
    Stevenson MD, Davis SE, Kanis JA (2006) The hospitalisation costs and out-patient costs of fragility fractures. Women’s Health Medicine Journal 3:149–151CrossRefGoogle Scholar
  10. 10.
    Kanis JA, Dawson A, Oden A, Johnell O, De Laet C, Jonsson B (2001) Cost-effectiveness of preventing hip fracture in the general female population. Osteoporos Int 12:356–361PubMedCrossRefGoogle Scholar
  11. 11.
    Fleurence R, Torgerson DJ, Reid DM (2002) Cost-effectivenesss of hormone replacement therapy for fracture prevention in young postmenopausal women: an economic analysis based on a prospective cohort study. Osteoporos Int 13:637–643PubMedCrossRefGoogle Scholar
  12. 12.
    Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T et al (2005) Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Br Med J 330:1003–1008CrossRefGoogle Scholar
  13. 13.
    Tinetti ME, Speechley M, Ginter SF (1988) Risk factors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707PubMedGoogle Scholar
  14. 14.
    Pluijm SM, Smit JH, Tromp EA, Stel VS, Deeg DJ, Bouter LM, Lips P (2006) A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling: results of a 3-year prospective study. Osteoporos Int 17:417–425PubMedCrossRefGoogle Scholar
  15. 15.
    Fleurence R, Iglesias CP, Torgerson DJ (2008) Economic aspects of osteoporosis treatments. In Treatment and prevention of osteoporosis. Arnold (in press)Google Scholar
  16. 16.
    Kind P (1996) The EuroQoL instrument: an index of health-related quality of life. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia, pp 191–201Google Scholar
  17. 17.
    Drummond MF, Sculpher MJ, Torrance G, O’Brien BJ, Stoddart G (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, OxfordGoogle Scholar
  18. 18.
    Birks YF, Porthouse J, Addie C, Loughney K, Saxon L, Baverstock M et al (2004) Randomised controlled trial of hip protectors among women living in the community. Osteoporos Int 15:701–706PubMedCrossRefGoogle Scholar
  19. 19.
    Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 140:1–55Google Scholar
  20. 20.
    Porthouse J, Birks YF, Torgerson DJ, Cockayne S, Puffer S, Watt I (2004) Risk factors for fracture in a UK population: a prospective cohort study. Q J Med 97:569–574Google Scholar
  21. 21.
    Department UK of Health (2004) Reference cost 2002/2003. Department of Health, LondonGoogle Scholar
  22. 22.
    The Chartered Institute of Public Finance and Accountancy (CIPFA) (2004) The Health Service Database. http://www.cipfa.org.uk
  23. 23.
    Netten A, Dennett J, Knight J (2004) Unit costs of health and social care. PSSRU, University of Kent, CanterburyGoogle Scholar
  24. 24.
    Beacon HJ, Thompson SG (1996) Multi-level models for repeated measurement data: application to quality of life data in clinical trials. Stat Med 15:2717–2732PubMedCrossRefGoogle Scholar
  25. 25.
    Omar RZ, Wright EM, Turner RM, Thompson SG (1999) Analysing repeated measurements data: a practical comparison of methods. Stat Med 18:1587–1603PubMedCrossRefGoogle Scholar
  26. 26.
    Rasbash J, Browne W, Goldstein H et al (2000) A user’s guide to MLwiN Version 2.1. Institute of Education, University of London, LondonGoogle Scholar
  27. 27.
    Dolan P (1997) Modeling valuations for EuroQol health states. Medical Care 35:1095–1108PubMedCrossRefGoogle Scholar
  28. 28.
    Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess (Winchester, England) 6:1–146Google Scholar
  29. 29.
    Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611–617PubMedCrossRefGoogle Scholar
  30. 30.
    Fleurence RL, Iglesias CP, Torgerson DJ (2006) Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature. Osteoporos Int 17:29–40PubMedCrossRefGoogle Scholar
  31. 31.
    Iglesias CP, Torgerson DJ, Bearne A, Bose U (2002) The cost utility of bisphosphonate treatment in established osteoporosis. QJM—Monthly Journal of the Association of Physicians 95:305–311PubMedGoogle Scholar
  32. 32.
    Puffer S, Torgerson DJ, Sykes D, Brown P, Cooper C (2004) Health related cost of women with symptomatic vertebral fractures. Bone 35:383–386PubMedCrossRefGoogle Scholar
  33. 33.
    O’Neill TW, Varlow J, Reeve J, Reid DM, Todd C, Woolfe AD, Silman AJ (1995) Fall frequency and incidence of distal forearm fracture in the UK. J Epidemiol Comm Hlth 49:597–598CrossRefGoogle Scholar
  34. 34.
    Cumming RG, Salkeld G, Thomas M, Szonyi G (2000) Prospective study of the impact of fear of falling on activities of daily living, SF-36 scores, and nursing home admission. J Gerontol 55A:M299–M305Google Scholar
  35. 35.
    Lin MR, Wolf SL, Hwang HF, Gong SY, Chen CY (2007) A randomized, controlled trial of fall prevention programs and quality of life in older fallers. J Am Geriatr Soc 55:499–506PubMedCrossRefGoogle Scholar
  36. 36.
    Nevitt M, Cummings S, Browner W, Seeley D, Canley J, Vogt T (1992) The accuracy of self-report of fractures in elderly women: evidence from a prospective study. A J Epidemiol 135:490–499Google Scholar
  37. 37.
    McColl E, JAcoby A, Thomas L, Soutter J, Thomas R, Harvey E, Garrat A, Bond J (2003) Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technol Assess 5:1–272Google Scholar
  38. 38.
    Bush T, Miller S, Golden A, Hale W (1989) Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 79:1554–1556PubMedCrossRefGoogle Scholar
  39. 39.
    Brazier JE, Roberts J (2004) The estimation of a preference-based measure of health from the SF-12. Medical Care 42:851–859PubMedCrossRefGoogle Scholar
  40. 40.
    Trombetti A, Herrmann F, Hoffmeyer P, Schurch M, Bonjour J, Rizzoli R (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731–737PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2008

Authors and Affiliations

  1. 1.Department of Health SciencesUniversity of YorkYorkUK
  2. 2.Centre for Health EconomicsUniversity of YorkYorkUK
  3. 3.Centre for Health EconomicsUniversity of YorkYorkUK
  4. 4.Department of Health SciencesUniversity of YorkYorkUK

Personalised recommendations